The observed correlations between CTRP9 and outcomes of interest were significant, even after adjustment for adiponectin level, with the exception of BMI, insulin and sICAM-1 in the T2DM group and IL-6 in the CAD+T2DM group. This evidence concerns the gene IL6 and type 2 diabetes mellitus.